Blue Sparrow LLC’s Merck MRK Stock Holding History

Blue Sparrow LLC’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.5M	Sell	136,900 -800	-0.6%	-$92.4K	0.28%	40
2025 Q4	$14.5M	Buy	+137,700	New	+$12.9M	0.27%	55

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blue Sparrow LLC's MRK Position: Q1 2026 in Review

Blue Sparrow LLC reduced its Merck (MRK) stake by 0.58% in Q1 2026, selling an estimated $92.4K and leaving 136,900 shares worth $16.5M. The position accounts for 0.28% of the portfolio, ranked #40.

Blue Sparrow LLC first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Blue Sparrow LLC held 136,900 shares of Merck worth $16.5M as of Q1 2026.
Blue Sparrow LLC sold 800 Merck shares in Q1 2026, an estimated $92.4K.
Merck made up 0.28% of Blue Sparrow LLC's portfolio in Q1 2026, its #40 holding.
Blue Sparrow LLC first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Blue Sparrow LLC's 13F filing for Q1 2026, filed 15 May 2026.